Navigation Links
Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
Date:4/7/2008

ROCKVILLE, Md., April 7, 2008 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the retirement of Ronald E. Cape, Ph.D. as Director, effective June 5, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Dr. Cape has been a Director of EntreMed since 2003, and has been instrumental in helping the Company chart its path forward in multi-mechanism oncology drugs. Dr. Cape was the co-founder, Chairman and CEO of Cetus Corporation, a world leader and pioneer in genetic engineering, including the discovery and development of the polymerase chain reaction (PCR), for which Cetus scientist Kary Mullis received the Nobel Prize. Cetus later merged with Chiron Corporation. Dr. Cape was the founding chairman of Darwin Molecular Corporation, which was later sold to Chiroscience plc. He was also a founding member of the Biotechnology Industry Organization and served as its President for three years.

Dr. Cape is a fellow of the American Academy of Arts and Sciences, the American Academy of Microbiology and the American Association for the Advancement of Science. He is the recipient of many awards, including the 2007 Biotechnology Heritage Award, and has held dozens of prestigious board positions in the public and private sectors. In recent years, Dr. Cape has been an investor in the field of biotechnology and a board member of various public and private companies. He has also served on the boards of Princeton University, Rockefeller University, the Whitehead Institute at MIT, and the Board of Rege
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. International Soccer Superstar Ronaldinho Signs With Nutrilite(TM)
2. MCM Completes Westwood Replacement Hospital - Ronald Reagan UCLA Medical Center
3. Philadelphia Ronald McDonald House(R) at Front & Erie Celebrates Grand Opening
4. Mayo Clinics Dr. Ronald C. Petersen Awarded Leon Thal Prize for Excellence in Dementia Research
5. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
6. St. Christophers Foundation For Children Ronald McDonald(R) Care Mobile Making Tri-State Visits to Provide Dental Care to Children at No Cost
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. East Ridge Retirement Village Announces Enhancement Plan
9. Increased Heart Risk Seen for Retired NFL Players
10. Mayo Clinic finds retired NFL players at increased risk for heart problems
11. AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wire-USNewswire/--AnarticlebyJanetWoodcock,M.D.,di...,titled"ADifficultBalance-PainManagement,DrugSafet...nglandJournalofMedicine. ,, (Logo: http://www.n...nthearticle,WoodcockdiscussesFDAeffortstostrikeaba...tandmanagingtherisksposedbyvariousanalgesics.Asexa...
(Date:11/25/2009).../--TheBayAreaAirQualityManagementDistrictisissuing...Alert forThursday,November26,2009whichbansburnin...indoorsandoutdoors. ,, "Cold,stillweatherwillco...adbent,executiveofficeroftheAirDistrict."We,reaski...rsandfellowcommunitymembersthisThanksgiving,andnot...
(Date:11/25/2009)...ncer who were treated with cisplatin-based chemoth...ological side effects and Raynaud-like phenomena, ...ccording to a new study published online November ...e . , Marianne Brydy, M.D., of the Department of...n, Norway, and colleagues conducted a cross-sectio...
(Date:11/25/2009)...ut of a collaboration between UCLA engineers and p...ly 10 million Americans who suffer from peripheral... of the arteries, peripheral arterial disease, or ...owed arteries reduce blood flow to the limbs. The ...sease, heart attack and stroke, and its progressio...
(Date:11/25/2009)...rt to draw definite conclusions, experts say, , ...In diabetic patients with blocked coronary arterie...t one year whether patients undergo bypass surgery... report. , Bypass surgery has been the standard...ery disease. However, less invasive approaches suc...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...ce" Includes Allscripts, Cisco, Citrix, Dell, Inte...er Education Programs Across the U.S. , , CHICAGO... of a coalition of technology innovation leaders w...Act details President Obama,s plan to improve heal...
...r,* Advanced Ribbon Dressing Features Hydrofiber(R..., a world-leading developer and marketer of innova...al care, announced today the launch of AQUACEL(R) ...oved wound dressing also offers reduced shrinkage ...
... 14 drugstore.com , inc. (Nasdaq: DSCM ), a le...nd pharmacy products, today announced that Dawn Le...board, and Tracy Wright, chief finance officer, wi...drugstore.com(TM) presentation will take place on ...
...4 Nile Therapeutics, Inc. (Nasdaq: NLTX ), ...apeutics for heart failure patients, today announc... , Update on CD-NP , , In March, Nile announce...nt to Nile, and in a follow-up teleconference, the...
...r Research Month activities include spring dedicat...VILLE, Ala., May 14 Today Intergraph(R) and the H... honor three remarkable cancer survivors at the In... at this inspirational gathering which coincided w...
...blacks less likely to suffer atrial fibrillation ,...hites are more likely than blacks to experience at...blacks have a higher prevalence of risk factors su...bers, or atria, quiver chaotically instead of beat...
Other Medicine News:Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 2Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 3Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 4Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 5Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 6Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 7Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 8Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 9Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 10Health News:ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber 2Health News:ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber 3Health News:ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber 4Health News:ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber 5Health News:drugstore.com, inc. to Present at the Upcoming JMP Securities Research Conference 2Health News:Nile Therapeutics Reports 2009 First Quarter Financial Results 2Health News:Nile Therapeutics Reports 2009 First Quarter Financial Results 3Health News:Nile Therapeutics Reports 2009 First Quarter Financial Results 4Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 2Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 3Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 4Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 5Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 6Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 7Health News:Risk Factor for Stroke More Common Among Whites 2
(Date:11/25/2009)...5/PRNewswire/--AMPACFineChemicalsLLC(AFC),asubsidi...uncedtodaythatitreceivedtheEnvironmentalResponsibi...ronmentalSummit,sponsoredbytheCaliforniaManufactur...ironmentalAssociation(IEA)andtheChemicalIndustryCo...tprestigiousawardavailablefromallthreeorganization...
(Date:11/25/2009)...--Reportlinker.comannouncesthatanewmarketresearchr...yEquipment-AGlobalMarketPerspective ,, http:...ent---A-Global-Market-Perspective.html ,, Risi...evelopingnationsisaprincipalfactorinfluencinggrowt...ssaboutbreastcancerhasallowedwomentocomeforwardfor...
(Date:11/25/2009)...-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedical...lydisruptivesurgicaltreatmentsforthespine,announce...er30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecal...rtheCompany,sproductsandwillincludecommentsfromman...edial-innumbersare1-877-407-4018fordomesticcallers...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Accumetrics Announces 2416 5M in New Capital Financing 5246 1Accumetrics Announces 2416 5M in New Capital Financing 5246 2Accumetrics Announces 2416 5M in New Capital Financing 5246 3Ethnic background may be associated with diabetes risk 58933 1Ethnic background may be associated with diabetes risk 58933 2Terumo Heart Inc 26apos 3Bs DuraHeart 26amp 3B 238482 3B Left Ventricular Assist System Featured at Future of Health Technology Summit 58931 1Terumo Heart Inc 26apos 3Bs DuraHeart 26amp 3B 238482 3B Left Ventricular Assist System Featured at Future of Health Technology Summit 58931 2Terumo Heart Inc 26apos 3Bs DuraHeart 26amp 3B 238482 3B Left Ventricular Assist System Featured at Future of Health Technology Summit 58931 3
...Activity Demonstrated in Metastatic Breast Cancer ...(Nasdaq: ENMD ), a clinical-stage pharmaceutical ...of cancer and inflammatory diseases, today,announc... Phase 2 study in,patients with metastatic breast ...der, M.D., Assistant Professor, Department of Medi...
...so Meets Primary Endpoint (p ...rates Lack of Systemic Exposure of XIAFLEX, Seri...IAFLEX injection, Conference call scheduled for ..., Pa., June 3 Auxilium,Pharmaceuticals, Inc. (Nas...icacy and safety results from the CORD I and CORD ...
Other Medicine Technology:EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting 2EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting 3EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 5Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 6Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 7Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 8Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 9Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 10Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 11
Looki 1TC
Digital Power M-Mode Doppler
Pakistani Watchmaker Forceps
Verte-Span Vertebral Body Replacement
Medicine Products: